Financials
Financial year 2025
Gross margin
€ 381,555
▲ 5% vs 2024
Profit
Growing€ 70,413
▲ 2% vs 2024
Debts
Normal€ 1 million
▲ 14% vs 2024
CONSORTIUM PHARMACEUTIQUE DE BELGIQUE from Ukkel, company number BE0874822610, closed financial year 2025 with a result of € 70,413 after tax. For that financial year CONSORTIUM PHARMACEUTIQUE DE BELGIQUE recorded a gross margin of € 381,555 and equity of € 340,056. Compared with financial year 2024, the result moved from € 69,162 to € 70,413. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on July 16, 2026.
What happened at CONSORTIUM PHARMACEUTIQUE DE BELGIQUE?
What happened at CONSORTIUM PHARMACEUTIQUE DE BELGIQUE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 70,413 (▲ 2% vs 2024). filed late Source: NBB ↗
- Marie Décarpentrie became a director. NBB
- Caroline Decarpentrie became a director. NBB
- New establishment in Ukkel. KBO
- New establishment in Ukkel. KBO
- New establishment in Frasnes-lez-Anvaing. KBO
- Start of the company according to the CBE. KBO
In short
From € 34,882 profit in 2021 to € 70,413 profit in 2025.
Paid € 125,686 in corporate taxes since 2021.
Best year ever: 2022, with € 83,014 profit.
On average € 159,000 of value added per employee in 2025.
A new publication or filing at CONSORTIUM PHARMACEUTIQUE DE BELGIQUE? We notify you, reason included.
Follow CONSORTIUM PHARMACEUTIQUE DE BELGIQUENeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Behind CONSORTIUM PHARMACEUTIQUE DE BELGIQUE are Marie Décarpentrie, Charles Ransart and Caroline Decarpentrie. The same people are also behind HARFANG.
Directors
According to the 2025 annual accounts
Marie Décarpentrie
Director
since 2024
Charles Ransart
Director
since 2024
Establishments
Establishment units
Physical locations of this company
Neerstallesteenweg 485
1180 Ukkel
Rue Emile Deltenre(SS) 3
7912 Frasnes-lez-Anvaing
Active since 11 July 2005
Engelandstraat 366
1180 Ukkel
Active since 1 October 2012
Homborch 71
1180 Ukkel
Active since 17 July 2013
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0874.822.610
- VAT number
- BE 0874.822.610
- Registered office
- Neerstallesteenweg 485, 1180 Ukkel
- Names & denominations
- CONSORTIUM PHARMACEUTIQUE DE BELGIQUE · COPHARBEL
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 1 July 2005
- Peppol
- Active · Active since 19 Feb 2026
- Activities · NACE
Detailhandel in farmaceutische producten
Apothekers
Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen
Detailhandel in medische en orthopedische artikelen
Detailhandel in medische en orthopedische artikelen in gespecialiseerde winkels